Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2008
06/05/2008WO2008066997A2 A method for quantitative measurement of cardiac biochemical markers
06/05/2008WO2008066996A2 A method to detect treponema pallidum immunological markers for the diagnosis of syphilis
06/05/2008WO2008066994A2 Application of surface plasmon resonance technology to maternal serum screening for congenital birth defects
06/05/2008WO2008066909A1 Optimized host cells for protein production
06/05/2008WO2008066691A2 Tes7 and antibodies that bind thereto
06/05/2008WO2008066629A2 Methods for quantitative proteome analysis of glycoproteins
06/05/2008WO2008066612A2 Methods and targets for indentifying materials for regulating hyper-proliferative skin conditions
06/05/2008WO2008066607A2 Device for detection of molecules in biological fluids
06/05/2008WO2008066584A2 Rapid analyte measurement assay
06/05/2008WO2008066554A1 Detecting and quantifying changes in the mass content of liquid storage containers
06/05/2008WO2008066483A1 Use of nalp5 in methods for diagnosis and therapy of parathyroid related disorders
06/05/2008WO2008066463A1 Detection conjugate
06/05/2008WO2008066440A1 Method for detecting mastitis of milking animals, a milking system and a computer program product
06/05/2008WO2008066176A1 Method for discriminating concrete specimen
06/05/2008WO2008066138A1 Fluorescent labeling agent and fluorescent labeling method
06/05/2008WO2008066064A1 Regulation of the activity of transcriptional factor stat by zinc ion
06/05/2008WO2008065897A1 Component separating device and chemical analysis device using the same
06/05/2008WO2008065806A1 Mass spectrometry of biological sample using immunoprecipitation
06/05/2008WO2008065694A1 Biomarkers of multiple sclerosis
06/05/2008WO2008065650A1 A method and system for diagnosing and treating a pest infested body
06/05/2008WO2008065636A2 Treatment of disease by modulating cf5 protein
06/05/2008WO2008065540A2 Method for the detection of post-translational modifications
06/05/2008WO2008065451A2 Compositions comprising macromolecular assemblies of lipid and surfactant
06/05/2008WO2008065415A2 Protein precipitation using a tag
06/05/2008WO2008065391A1 Uses and methods relating to ndr kinase expression and/or activity
06/05/2008WO2008065324A1 System and method for qualitative and quantitative analysis of gaseous components of multiphase hydrocarbon mixtures
06/05/2008WO2008065220A1 Protein-expression patterns in mononuclear cells as cardiovascular-disease markers
06/05/2008WO2008065047A1 Capture of mycobacteria like micro-organisms
06/05/2008WO2008064884A1 Activated her3 as a marker for predicting therapeutic efficacy
06/05/2008WO2008064883A1 In vitro method for the diagnosis and early diagnosis of neurodegenerative disorders
06/05/2008WO2008064782A1 Test for wetting characteristics
06/05/2008WO2008064684A1 Screening method using sample adsorption on filter paper
06/05/2008WO2008064670A2 Biomarker for diagnosing pancreatic cancer
06/05/2008WO2008064667A2 Method for the production of elemental mercury from mercury compounds
06/05/2008WO2008064570A1 The use of granulin-epithelin precursor (gep) antibodies for detection and suppression of hepatocellular carcinoma (hcc)
06/05/2008WO2008064497A1 Integrated moisture, length, and strength tester
06/05/2008WO2008064408A1 Generation of enriched populations of neural progenitor cells and their progeny
06/05/2008WO2008064402A1 Downhole fluid property chromatography
06/05/2008WO2008043566A3 Compositions and methods for treating and diagnosing irritable bowel syndrome
06/05/2008WO2008040328A3 Diagnosis of infections or inflammatory diseases of the airways and lungs associated with heart failure
06/05/2008WO2008034621A3 Nucleotide phosphorylase for the prophylaxis, treatment or diagnosis of acute lung injury (ali)
06/05/2008WO2008032217A3 Method for investigating the response to a treatment with a monoclonal antibody
06/05/2008WO2008030252A3 Compositions and methods of screening apoproteins
06/05/2008WO2008025316A3 Sample preparation method for quantitative analysis of samples containing amino acids
06/05/2008WO2008016691A3 Methods and apparatus for treating samples with acoustic energy
06/05/2008WO2008015254A3 Means and methods for assessing the risk of cardiac interventions based on gdf-15
06/05/2008WO2008013454B1 Immunogenic compounds and protein mimics
06/05/2008WO2008011158A3 Method of detecting and/ or measuring hepcidin in a sample
06/05/2008WO2008007280A3 Assay system and method
06/05/2008WO2007146267A3 Disease model incorporation into an artificial immune system (ais)
06/05/2008WO2007144781A3 Diagnostic methods and kits utilizing antibodies for metalloproteases
06/05/2008WO2007144001A3 Embryo quality assessment based on blastomere division and movement
06/05/2008WO2007120298A3 Methods, substrates and probes for assaying n-glycosidase activity
06/05/2008WO2007118214A3 Antibody compositions and methods for treatment of neoplastic disease
06/05/2008WO2007115075A3 Blood test kit
06/05/2008WO2007075565A3 Diagnostic system for the detection and diagnosis of skin cancer
06/05/2008WO2007061715A3 Detection, generation and uses of atherosclerosis-protective vascular endothelium
06/05/2008WO2007051604A3 Novel 2,4-dichlorophenoxy acetic acid derivatives and use thereof in diagnostic and analytic detection methods
06/05/2008WO2007035405A3 In-vivo and in-vitro method for detecting amyloid deposits having at least one amyloidogenic protein
06/05/2008WO2006091942A3 Methods of expressing, purifying and characterizing concanavalin a, mutants thereof, and sensors including the same
06/05/2008WO2006078892A3 Use of a novel prostate specific membrane antigen for cancer diagnosis and therapy
06/05/2008US20080134370 Novel Altered Gene from Rice Anthranilic Acid Synthase Gene Oasa2 and Use Thereof
06/05/2008US20080134367 Nucleic acids encoding monomers of a type II serine proteinase inhibitor
06/05/2008US20080133148 Method For Checking Indoor Environment
06/05/2008US20080133147 Method for Predicting Concentration Distribution of Microparticles, Device for Analysis, Program Product for Predicting Concentration Distribution of Microparticles, Building and Device for Diffusing Microparticles Designed by Using the Method for Prediction
06/05/2008US20080133146 Device Having a Trend-Indicating Display
06/05/2008US20080133144 Method of Systematic Analysis of Relevant Gene in Relevant Genome Region (Including Relevant Gene/Relevant Haplotype)
06/05/2008US20080133143 Methods, systems, and software for identifying functional biomolecules
06/05/2008US20080133142 Sequence pattern descriptors for transmembrane structural details
06/05/2008US20080133141 Weighted Scoring Methods and Use Thereof in Screening
06/05/2008US20080132693 Bead emulsion nucleic acid amplification
06/05/2008US20080132685 Methods and Compositions for Detecting Amyotrophic Lateral Sclerosis
06/05/2008US20080132683 Purification of immunoglobulins from solution (hybridoma cell culture supernatants, animal plasma or sera, or colostrum); solid phase synthesis
06/05/2008US20080132551 Positive allosteric modulators of the nicotinic acetylcholine receptor
06/05/2008US20080132474 Breast cancer screening and treatment methods
06/05/2008US20080132465 Introducing a serum sample into a separation column having a solid phase; retaining with the solid phase an iron component; removing the iron component from the solid phase
06/05/2008US20080132462 Administering an agent which inhibits the expression or activity of p46 Shc and/or p52 Shc; determining whether an agent inhibits the phosphorylation of p46 Shc or p52 Shc
06/05/2008US20080132460 Screening for a compound which inhibits p62/ubiquitin binding; detecting the formation of inclusion bodies in neurodegenerative diseases; screening for therapeutic agents that disperse the inclusions
06/05/2008US20080132447 kit; oligonucleotide; diagnose and treat carnitine deficiency
06/05/2008US20080132446 Uses of neuronal pannexins for therapy and diagnosis in mammals
06/05/2008US20080132427 Comprising vertebrate cell having both luciferase and heterologous proliferation factor receptor encoding nucleic acids
06/05/2008US20080132425 Method for Determining Protein Solubility
06/05/2008US20080132423 Isolated cell lines for screening drug candidates and identifying novel expressed genes and druggable targets
06/05/2008US20080132422 Based on substrate integrated multifunctional microelectrode arrays implementing stem cell technology; normal and pathogenic characteristics
06/05/2008US20080132421 Array-based detection of genetic alterations associated with disease
06/05/2008US20080132416 Rapid, efficient sequence space searching; bioinformatics
06/05/2008US20080131978 Labeled specific binding material conjugated microspheres for use in immuno-quantitative determinationi; immunodiagnostics
06/05/2008US20080131977 Multicompartment immunoassay apparatus for use in drug screening and pregnancy testing
06/05/2008US20080131976 Novel G protein coupled receptor protein, DNA its ligand
06/05/2008US20080131974 Systems And Methods For Determining Carbon Credits
06/05/2008US20080131973 Laser ionization mass spectrometry using supersonic jet/resonance-enhanced multiphoton ionization
06/05/2008US20080131972 Bioreactor comprising multicompartment cells and sensor for monitoring hydrogen ion and oxygen concentrations
06/05/2008US20080131971 Occult blood testing device
06/05/2008US20080131970 Biochemical reaction cartridge
06/05/2008US20080131931 Expression vector comprising nucleotide sequences coding protein which binds interleukin-10 related t cell-derived inducible factor (IL-TIF); for use in targeting cell for surgical removal
06/05/2008US20080131921 Using tryptophan degratory products as diagnostic indicators of depression and alzheimer's diseases
06/05/2008US20080131918 Cholesterol Assay
06/05/2008US20080131917 Products and methods for single parameter and multiparameter phenotyping of cells
06/05/2008US20080131916 Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
06/05/2008US20080131915 GPR30 estrogen receptor in breast cancers